Biotech Company With Clinical Operations Developing Psychedelic Medicine To Treat Addiction

First 3 UK Clinics Opening In 2021, Targeting 20 Clinics By 2024 ~$100M In Revenue

Sponsored
Awakn Life Sciences Corp.'s Newsfeed